Updated Articles

  1. ReaDI-Watch at MedTech Rising 2025

    ReaDI-Watch is attending MedTech Rising 2025 to connect with industry leaders and gain insights into Ireland’s medtech innovation landscape. Learn more here.
  2. IRDG Funding Innovation 2025: Expert Insights & Stories

    IRDG Funding Innovation 2025: Expert Insights & Stories
  3. Prof. Gerry Byrne meets with the President of acatech, Germany

    Chief Scientific Officer ReaDI-Watch meets President of acatech
  4. Prof. Byrne attends opening of the CIRP 2025 General Assembly

    Prof. Gerry Byrne, Chief Scientific Officer of ReaDI-Watch and a distinguished figure in international manufacturing research, has attended the opening of the 2025 CIRP General Assembly this week. The event is being held at the Stockholm Centre...
  5. Identifying Qualifying R&D in Software

    Learn how to identify qualifying R&D in software and how ReaDI-Watch helps uncover, track, and validate real innovation across agile delivery workflows.
  6. Push vs. Pull: How ReaDI-Watch Captures Both Sides of Innovation

    Explore how R&D emerges through both internal push and external pull—and why harnessing both requires distinct strategies, structures, and support.
  7. Ireland - Filing the Corporate Tax Return (with R&D Tax Credits)

    Ireland - Filing the Corporate Tax Return (with R&D Tax Credits)
  8. Amplify 2025 | IRDG's Leading R&D Event

    ReaDI-Watch showcased Innovation and R&D platform at IRDG Amplify 2025, aligning innovation, AI, and R&D Tax Credit compliance with industry leaders.
  9. Celebrating Irish Manufacturing Excellence at the MEA Awards 2025

    ReaDI-Watch's Gerry Byrne attends MEA Awards 2025, celebrating Lawrence Engineering and top innovators shaping Irish manufacturing excellence.
  10. Accounting for R&D and Innovation: Creating Value in your Company

    Accounting for Research and Development (R&D) is a crucial consideration for many businesses as it fuels innovation and future growth. However, how R&D investments are accounted for can significantly impact a company’s financial statements, particul...